Citius Oncology Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Citius Oncology.

Price Target: $0.00 (0.00%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Citius Oncology is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	1	1	1	0
Buy	0	0	0	0
Hold	1	1	1	1
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 23, 2025
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Initiates $3	Strong Buy	Initiates	$3	+67.60%	Nov 27, 2024
Jason Kolbert EF Hutton	EF Hutton	Strong Buy Maintains $6	Strong Buy	Maintains	$6	+235.20%	Aug 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

74.34M

EPS This Year

-0.49

from -0.31

EPS Next Year

0.05

from -0.49

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	-	-	-	-	74.34M	106.16M
Revenue Growth	-	-	-	-	-	42.80%
EPS	-0.32	-0.19	-0.31	-0.49	0.05	0.54
EPS Growth	-	-	-	-	-	960.00%
Forward PE	-	-	-	-	35.10	3.31
No. Analysts	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	76.5M	109.3M
Avg	n/a	74.3M	106.2M
Low	n/a	71.4M	102.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	47.0%
Avg	-	-	42.8%
Low	-	-	37.2%

EPS Forecast

EPS	2025	2026	2027
High	-0.50	0.05	0.56
Avg	-0.49	0.05	0.54
Low	-0.47	0.05	0.52

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	991.2%
Avg	-	-	960.0%
Low	-	-	918.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.